Kolkata-based Suraksha Diagnostic is launching an offer for sale worth ₹846 crore, giving partial exit to OrbiMed Asia and reducing promoter holding. The company operates primarily in West Bengal and plans to expand its services and markets. The IPO values it at 73.5 times its annualized FY25 earnings.
